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the level of ROS was significantly increased by 4-OH-
AOH, neither DNA strand breaks nor enhanced levels of 
formamidopyrimidine-DNA-glycosylase (FPG)-sensitive 
sites were observed. In contrast, AOH induced significant 
DNA damage in KYSE510 cells. Less pronounced or even 
absent effects of hydroxylated metabolites compared to 
the parent compounds might at least partly be explained 
by their poor cellular uptake. Glucuronidation as well as 
sulfation appear to have only a minor influence. Instead, 
methylation of 4-OH-AOH seems to be the preferred way 
of metabolism in KYSE510 cells, whereby the toxico-
logical relevance of the methylation product remains to be 
clarified.
Keywords Alternaria alternata · Reactive oxygen 
species · Topoisomerase inhibition · KYSE510 · Human 
phase I and II metabolism · Mycotoxin conjugates
Introduction
Fungi of the genus Alternaria are ubiquitously present in 
nature, causing a diversity of plant diseases (Mikami et al. 
1971; Tsuge et al. 2013). As a result of their wide sporu-
lation and growth range, they infect plants and food crops 
in nearly every stage of production, even during storage at 
low temperatures. The excessive production of secondary 
metabolites by Alternaria spp. under diverse conditions 
enables them to be hazardous to the health of humans and 
animals (Asam and Rychlik 2013; CONTAM 2011; Lee 
et al. 2015). Seventy of these secondary metabolites have 
been classified as mycotoxins or phytotoxins (Barkai-
Golan 2008). Alternariol (AOH) and alternariol mono-
methyl ether (AME) (Fig. 1) represent two of the major 
mycotoxins produced by Alternaria alternata that have 
Abstract Studies on the genotoxicity of Alternaria myco-
toxins focus primarily on the native compounds. Alternariol 
(AOH) and its methyl ether (AME) have been reported to 
represent substrates for cytochrome P450 enzymes, gener-
ating hydroxylated metabolites. The impact of these phase 
I metabolites on genotoxicity remains unknown. In the 
present study, the synthesis and the toxicological effects 
of the metabolites 4-hydroxy alternariol (4-OH-AOH) and 
4-hydroxy alternariol monomethyl ether (4-OH-AME) are 
presented and compared to the effects of the parent mol-
ecules. Although the two phase I metabolites contain a 
catecholic structure, which is expected to be involved in 
redox cycling, only 4-OH-AOH increased reactive oxygen 
species (ROS) in human esophageal cells (KYSE510), 4 
times more pronounced than AOH. No ROS induction was 
observed for 4-OH-AME, although the parent compound 
showed some minor impact. Under cell-free conditions, 
both metabolites inhibited topoisomerase II activity com-
parable to their parent compounds. In KYSE510 cells, both 
metabolites were found to enhance the level of transient 
DNA–topoisomerase complexes in the ICE assay. Although 
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been ascribed as cytotoxic and genotoxic in vitro (Pfeiffer 
et al. 2007a). Fehr et al. (2009, 2010) reported DNA strand-
breaking properties of AOH and AME in vitro in conse-
quence of topoisomerase poisoning. Additionally, muta-
genic and estrogenic effects in cell culture were described 
by Lehmann et al. (2006) and Brugger et al. (2006). Some 
of these activities might be caused by phase I metabo-
lites of AOH and AME. Pfeiffer et al. (2007b) postulated 
that during xenobiotic metabolism, metabolites of AOH 
or AME, arising from hydroxylation through cytochrome 
P450 (CYP) enzymes, have a reactive catechol or hyd-
roquinone structure. Such compounds are supposed to 
undergo redox cycling inducing the generation of reactive 
oxygen species potentially leading to DNA damage. Thus, 
despite data concerning toxicity and other effects of AOH 
and AME, their phase I metabolites should not be neglected 
for a proper risk evaluation.
Pfeiffer et al. (2007b, 2008) incubated human micro-
somes with AOH and AME confirming the formation of 
metabolites hydroxylated at C-2, C-4 and C-8. Furthermore, 
CYP1A1, commonly occurring in extrahepatic tissues such 
as the esophagus (Lechevrel et al. 1999), was the most active 
monooxygenase for AOH and especially for AME (Pfeiffer 
et al. 2008; Schreck et al. 2012). Thus, phase I metabolites 
may be generated in a tissue-specific manner after ingestion 
of AOH or AME and may at least contribute to the induc-
tion of esophageal cancer (Liu et al. 1991). CYP1A1 belongs 
to the isoenzyme family of CYPs which is mainly regulated 
by the aryl hydrocarbon receptor (AhR) pathway. As hypoth-
esized by Schreck et al. (2012), AOH and AME are inducers 
Fig. 1  a Chemical structure of alternariol (AOH), alternariol mon-
omethyl ether (AME), 4-hydroxy alternariol (4-OH-AOH) and 
4-hydroxy alternariol monomethyl ether (4-OH-AME), b chemical 
synthesis of 4-OH-AOH and 4-OH-AME. Et ethyl, t-Bu tert. Butyl, 
DMF N,N-dimethylformamide, CSA camphorsulfonic acid, Bn ben-
zyl, Ac acetyl
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of the AhR pathway, which enhances the expression of sev-
eral metabolizing enzymes especially CYP monooxyge-
nases. Experiments with murine AhR-deficient Hepa-1c1c12 
cells did not show induction of CYP expression after incuba-
tion with AOH or AME supporting the hypothesis. Also in 
line are the findings of Pahlke et al. (2015), who analyzed 
the impact of Alternaria toxins on CYP1A transcription and 
activity in different human tumor cells with the objective to 
identify potential organ specificity. AOH caused an induction 
of CYP1A most prominently in esophageal cells (KYSE510) 
after 24-h incubation, whereas AME only mediated an 
increase in liver cells. Because of the enhanced sensitivity of 
KYSE510 cells toward AOH, the experiments were repeated 
in AhR-suppressed KYSE510 cells. CYP1A1 induction 
by AOH was significantly reduced compared to the AhR-
expressing cells, but AhR suppression was of no relevance 
for the DNA-damaging properties of AOH. The data suggest 
that at least AOH promotes its xenobiotic metabolism by 
AhR-dependent induction of CYP enzymes in cells.
The lacking impact of AhR suppression on DNA dam-
age might be due to the initiation of cellular defense 
mechanisms. As recently reported, AME and, to a greater 
extent, AOH were found to modulate the cellular redox sta-
tus in human colon cancer cells (HT29), human liver can-
cer cells (HepG2) and especially KYSE510 cells (Pahlke 
et al. 2015; Tiessen et al. 2013a). The increase in reactive 
oxygen species (ROS) results from an imbalance between 
ROS formation and elimination by scavengers and might 
on the one hand affect directly DNA, proteins or lipids 
and on the other hand act as signaling molecules e.g., in 
the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) path-
way. Nrf2 is bound by Kelch-like ECH-associated protein 
1 (Keap1) in the cytosolic fraction (Itoh et al. 1999). Elec-
trophiles and ROS provoke the release of the Nrf2 from 
the Nrf2–Keap1 complex, which can now translocate into 
the nucleus where it binds in a complex with small Maf 
proteins to the antioxidant response element (ARE) and 
initiates the transcription of anti-oxidative enzymes like 
glutathione-S-transferases (GST), γ-glutamylcysteine syn-
thetases (γ-GCL) or UDP-glucuronosyltransferases (UGT). 
Furthermore, Miao et al. (2005) reported a direct regulation 
of Nrf2 by AhR activation leading to an elaborated drug-
metabolizing detoxification mechanism made up of phase I 
and II enzymes. As stated above, the catecholic structure of 
the phase I metabolites may contribute to the induction of 
ROS. It can therefore be hypothesized that biotransforma-
tion of AOH and AME plays an important role in the sever-
ity of the toxic effects. Until now, little is known about the 
impact of possible metabolites of AOH and AME. It entails 
the necessity of further investigation of the phase I metabo-
lites to better assess the health risk of Alternaria toxins.
In the present study, the question was addressed whether 
phase I metabolites of AOH and AME with their highly 
reactive catechol or hydroquinone structure might exceed the 
toxicological effects of their parent compounds. In a previ-
ous study, KYSE510 cells reacted most sensitive toward 
AOH regarding ROS production and CYP1A induction com-
pared to HepG2 or HT29 cells (Pahlke et al. 2015). Based on 
these results and a potential link between a high incidence of 
esophageal cancer in a province of China and the consump-
tion of grains heavily contaminated with Alternaria (Liu 
et al. 1991, 1992), esophageal tumor cells were chosen in 
this study. In order to compare the effects of the metabolites 
with those of the parent toxins, the impact on cytotoxicity, 
induction of ROS generation, topoisomerase targeting, geno-
toxicity and cellular uptake were investigated in detail.
Materials and methods
Chemicals and reagents
AOH and AME were purchased from Sigma-Aldrich Che-
mie GmbH (Taufkirchen, Germany). 4-OH-AOH and 
4-OH-AME were chemically synthesized as shown in 
Fig. 1. Experimental details are described in the Online 
Resource 1. The products were purified by semi-prepar-
ative HPLC (Knauer, Germany), characterized by NMR 
spectroscopy (Bruker Avance UltraShield 400, Ettlin-
gen, Germany) and HRMS analysis (Thermo Scientific 
LTQ Orbitrap XL Hybrid FTMS, Waltham, MA, USA), 
and their purity (>95 %) was analyzed by HPLC-DAD 
(Agilent 1200, Waldbronn, Germany) at a wavelength of 
340 nm. Etoposide (ETO) was bought from Sigma-Aldrich 
(Taufkirchen, Germany). Kinetoplast DNA (kDNA) and 
topoisomerase IIα were obtained from TopoGEN\ (Port 
Orange, FL, USA). Topoisomerase IIα and IIβ-specific rab-
bit polyclonal antibodies, specific rabbit polyclonal IgG 
antibody (sc-101762) and goat anti-rabbit IgG-HRP anti-
body (sc-2004) were purchased from Santa Cruz Biotech-
nology (Heidelberg, Germany). The DNA repair enzyme 
formamidopyrimidine-DNA-glycosylase (FPG) from 
Escherichia coli was obtained from New England Biolabs 
(Frankfurt am Main, Germany). Sulfatase (from Aero-
bacter aerogenes, Type VI) and β-glucuronidase (from E. 
coli) were purchased from Sigma-Aldrich Chemie GmbH 
(Taufkirchen, Germany). All other chemicals and reagents 
were purchased from Carl Roth GmbH Co. KG (Karlsruhe, 
Germany) or Sigma-Aldrich Chemie GmbH unless stated 
otherwise.
Cell culture
The human esophageal carcinoma cell line KYSE510 
was obtained from the German Collection of Microorgan-
isms and Cell Cultures GmbH (DSMZ, Braunschweig, 
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Germany). Culture media and supplements were purchased 
from GIBCO Invitrogen (Karlsruhe, Germany). KYSE510 
cells were cultivated in Rosswell Park Memorial Institute 
(RPMI) 1640 medium supplemented with 10 % fetal calf 
serum (FCS) and 1 % penicillin/streptomycin (50 units/mL 
and 50 µg/mL, respectively). The Chinese hamster ovary 
cell line CHO-ARE-luciferase as described in Heiss et al. 
(Heiss et al. 2014) was cultivated in Dulbecco’s Modified 
Eagle’s Medium (DMEM) with 10 % FCS, 4 µg/mL puro-
mycin and 1 % l-glutamine. Both cell lines grew in humid-
ified incubators at 37 °C and 5 % CO2. Cells were routinely 
tested for the absence of mycoplasma contamination.
Cytotoxicity assay (WST‑1)
Mitochondrial activity as a measure of cytotoxicity was 
determined in KYSE510 esophageal carcinoma cells with 
the WST-1 test kit (Roche Applied Science, Mannheim, 
Germany). 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-
disulfophenyl)-2H-tetrazolium is reduced to a water-
soluble formazan salt by mitochondrial enzymes of the 
cells. The formazan salt can be detected photometrical. 
1,300 KYSE510 cells/well were seeded in 96-well plates 
and cultivated for 48 h. Thereafter, cells were incubated 
with AOH and 4-OH-AOH or the positive control Triton 
X-100 for 24 h in serum-containing medium. The assay 
was performed according to the manufacturer’s protocol, 
and absorbance was measured at 450 nm with a reference 
wavelength of 650 nm with a plate reader (Victor3 V, Perkin 
Elmer, Waltham, MA, USA). Cell viability was specified 
as mitochondrial activity and calculated as treated cells to 
control cells × 100 (% T/C).
Dichlorofluorescein (DCF) assay
The production of cellular ROS, indicative for increased 
oxidative stress, was measured by the DCF assay as 
reported in Keston and Brandt (1965). The assay is 
based on the uptake of the non-fluorescent dihydrodi-
chlorofluorescein diacetate and intracellular de-esterifi-
cation to dihydrodichlorofluorescein, which is oxidized 
to 2′,7′-dichlorofluorescein by reactive oxygen species. 
DCF can be measured fluorometrically at an excitation of 
485 nm with the multimode plate reader Victor3 V (Perk-
ing Elmer, Waltham, MA, USA). KYSE510 cells were 
seeded 48 h prior to incubation in a black 96-well plate. 
Cells were incubated with AOH, AME, 4-OH-AOH, 4-OH-
AME or menadione (MEN), used as positive control com-
pound, in colorless serum-free medium for 1 h. Oxidative 
stress was determined as relative fluorescence and calcu-
lated as treated cells over control cells (oxidative stress 
(%) = 100 × (emission of treated sample)/(emission of 
control).
Nrf2 reporter gene assay
The ARE-dependent luciferase assay was performed as 
described in Heiss et al. (2014). Transfected CHO cells 
were plated at a density of 6 × 105 cells/well in 96-well 
plates and cultivated for 4 h in serum-containing medium. 
Subsequently, cells were incubated with AOH, AME, 
4-OH-AOH, 4-OH-AME (solvent vehicle 0.5 % DMSO) 
or the positive control 2-cyano-3,12-dioxoolean-1,9-dien-
28-oic acid (CDDO; 100 nM) for 20 h in serum-contain-
ing medium. After the incubation, the cells were washed 
with PBS twice and frozen at least for 1 h at −80 °C. Then 
50 µL luciferase lysis buffer (Promega; E1531) was added 
to each well and shaken for 10 min. 40 µL of the cell lysate 
was transferred into a black 96-well plate. The fluorescence 
signal of GFP was measured at 485-nm excitation and 520-
nm emission wavelength, and the ATP and luciferin solu-
tion were added and measured afterward automatically by 
the Genios Pro plate reader (Tecan, Grödig, Austria). The 
ratio of chemiluminescence/GFP fluorescence was formed 
and normalized to solvent control (Nrf2 activation = (ratio 
of treated sample)/(ratio of solvent control).
Single cell gel electrophoresis (comet assay)
Single cell gel electrophoresis was performed according 
to Tice et al. (2000). A total of 300,000 KYSE510 cells 
were spread into Petri dishes (Ø 5.5 cm) and allowed to 
grow for 48 h. Subsequently, cells were treated with AOH, 
AME, 4-OH-AOH and 4-OH-AME for 1 h in serum-free 
medium. UV-B light (λ = 312 nm; dosage: 448 J/cm2) was 
used as a positive control. Subsequent working steps were 
done according to Pelka et al. (2009). Additional treatment 
was performed with the DNA repair enzyme FPG from E. 
coli (New England Biolabs, Vienna, Austria) according to 
the manufacturer’s protocol, using 2 × 0.08 units FPG for 
30 min at 37 °C. This allows the detection of additional 
oxidative damage to DNA bases (Hatahet et al. 1994; 
Tchou et al. 1994). Fluorescence microscopy was per-
formed with a Zeiss Axioskop 40 FL (λex = 546 ± 12 nm; 
λem ≥ 590 nm) after staining with ethidium bromide. Slides 
were subjected to computer-aided image analysis (Comet 
Assay IV System, Perceptive Instruments, Suffolk, UK), 
scoring 2 × 50 randomly picked cells per slide. The results 
were parameterized with respect to intensity of DNA in 
the comet tail and calculated as percentage of overall DNA 
intensity in the respective cell.
Decatenation assay
The cell-free decatenation assay was used to determine 
the catalytic activity of topoisomerase IIα to release DNA 
minicircles from kDNA. A mixture of topoisomerase IIα 
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(TopoGEN) and supercoiled kDNA (200 ng) was incu-
bated for 60 min at 37 °C with the respective AOH, AME, 
4-OH-AOH and 4-OH-AME concentrations according 
to the manufacturer’s protocol with slight modifications 
(TopoGEN, Inc., Florida, USA). ETO (50 µM) served as a 
positive control. To stop the reaction, 5 µL loading buffer 
was added and samples were electrophoresed in 1 % aga-
rose gel. The gel was dyed with ethidium bromide (10 µg/
mL in distilled water) and documented by digital photogra-
phy under UV light using the LAS 4000 (Fujifilm, Tokyo, 
Japan).
In‑vivo‑complex‑of‑enzyme (ICE) assay
Briefly, 3 × 106 KYSE510 cells were seeded in Petri dishes 
(Ø 15 cm) for 72 h. Afterward, cells were incubated with 
AOH, AME, 4-OH-AOH, 4-OH-AME or 50 µM of the 
topoisomerase poison ETO as a positive control for 1 h 
in serum-free medium. The cell lysate was layered on a 
cesium chloride gradient and centrifuged at 100,000×g 
for 22 h at 20 °C. 300 µL fractions of each sample were 
collected. The fractions were blotted on a nitrocellulose 
membrane, and the topoisomerase complexes were con-
jugated with topoisomerase IIβ-specific rabbit polyclonal 
antibodies (Santa Cruz Biotechnology). An anti-rabbit IgG 
peroxidase conjugate was used as secondary antibody. The 
respective chemiluminescent signals (Lumi-GLO, Cell 
Signaling Technology, Danvers, USA) were analyzed using 
the LAS 4000 (Fujifilm, Tokyo, Japan). Arbitrary light 
units were referred to the DNA content of the fractions and 
plotted as treated sample over control × 100 (%, T/C).
Cellular uptake and metabolism of AOH, AME, 
4‑OH‑AOH and 4‑OH‑AME (LC‑MS/MS)
To analyze the cellular uptake of AOH, AME, 4-OH-AOH 
and 4-OH-AME, the concentration of the four substances 
in the medium and in the cells after 1 h of incubation was 
quantified by LC-ESI-MS/MS. KYSE510 cells (250,000) 
were seeded into Petri dishes (Ø 5.5 cm), and after 72 h the 
cells were treated with 10 µM AOH; AME, 4-OH-AOH, 
4-OH-AME or 1 % DMSO for 1 h in serum-free medium. 
The incubation medium was transferred into a 15-mL 
tube and stored at −80 °C until further analysis. The cell 
layer was washed twice with PBS and frozen at −80 °C. 
After thawing of the cells, 400 µL bidest H2O was added 
to the cells which were scratched off the Petri dish using 
a cell scraper and transferred into a reaction tube. Cells 
were lysed by three freeze–thaw cycles (−80 °C, 1 h) and 
subsequent sonification (15 s). Cell lysates were centri-
fuged for 10 min at 18,000g at 4 °C. 10 µL of the super-
natant was withdrawn to determine the protein amount by 
a Bradford assay. The supernatant and the cell pellet were 
homogenized by sonification again and extracted three 
times with 600 µL ethyl acetate. The fractions were col-
lected for each sample and evaporated to dryness in the 
S-Concentrator SA-VC-300H with the diaphragm pump 
Pu-Hy-CH (H. Saur, Reutlingen, Germany). The residue 
was diluted in PBS, and three aliquots, a 100 µL of each 
cell lysate and medium supernatant was filled in reaction 
tubes. The aliquots were either incubated with glucuroni-
dase, sulfatase or phosphate buffer for 2 h at 37 °C. The 
reaction was stopped by adding ethyl acetate (−20 °C). 
The samples were extracted, the residues dissolved in 
methanol and analyzed. LC-ESI-MS/MS analysis was 
carried out using a TSQ vantage triple quadrupole mass 
spectrometer interfaced with an Accela autosampler and 
an Accela 1250 pump all from Thermo Fisher Scientific 
(Germany). The system was operated utilizing the Xcalibur 
software 2.1 (Thermo Fisher Scientific, Germany). Sepa-
ration was achieved on a Luna 3u C18 column (1.0 mm 
(i.d.) × 100 mm, Phenomenex, Torrance, CA) with the 
matching pre-column using gradient elution with H2O (sol-
vent A) and acetonitrile (solvent B) as eluents, both con-
taining 0.1 % formic acid. Gradient elution was performed 
as follows: 0 min, 30 % B; 5 min, 30 % B; 7 min, 100 % 
B; 12 min, 100 % B. The column oven temperature was set 
to 30 °C, and the injection volume was 20 μL. The flow 
rate was 0.1 mL/min. The following parameters were used 
to operate the triple quadrupole mass spectrometer: nega-
tive ion mode; multiple reaction monitoring; spray voltage, 
−3.0 kV; capillary temperature, 250 °C; vaporizer tempera-
ture, 100 °C; Q1 peak width [FWHM], 0.7; Q3 peak width 
[FWHM], 0.7; aux gas pressure, 5 arb; sheath gas pressure, 
20 arb; collision gas pressure, 1 mTorr. The optimized col-
lision energies and fragment ions for the investigated ana-
lytes are listed in Table 1.
Preparation of calibration solutions and spiking 
procedure
Solid reference standards were dissolved to a concentration 
of 1 mg/mL in methanol. From the 1 mg/mL standard, dilu-
tion series were created in methanol to yield concentrations 
of 1, 5, 10, 50, 100, 150, 200 ng/mL. These standards were 
utilized to generate a calibration curve for external cali-
bration purpose. To evaluate the extraction efficiency and 
the matrix effects preliminary spiking experiments were 
performed. One concentration of each toxin (2.5 µM) was 
spiked to the scratched cells or the medium in triplicate 
before the extraction to cover the whole sample prepara-
tion procedure. Before analysis, the spiked samples were 
diluted 1:10. Quantitative data evaluation was performed 
using the Xcalibur Quan Browser software.
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Data analysis
For statistical evaluation, the Origin software was used. All 
results represent the mean of at least 3 independent experi-
ments ± standard deviation (SD). Concentration-depend-
ent data were statistically analyzed as stated in the figure 
legends.
Results
Impact of AOH and 4‑OH‑AOH on mitochondrial 
activity
Initial tests on the impact of hydroxylation on cytotoxicity 
were performed with the WST-1 assay, measuring mito-
chondrial activity. Cell viability of KYSE510 cells was 
affected by AOH and 4-OH-AOH after 24 h of incuba-
tion (Fig. 2). The mitochondrial activity was significantly 
reduced by 25 µM AOH by about 20 ± 10 %, whereas 
25 µM 4-OH-AOH caused only a minor reduction in 
about 10 to 90 ± 7 % yet without statistical significance. 
At a concentration of 50 µM, cell viability dropped to 
about 57 ± 12 % for AOH and 50 ± 15 % for 4-OH-AOH, 
respectively. Triton X, a potent detergent, was used as a 
positive control and totally inhibited mitochondrial activ-
ity. In summary, no significant difference between metabo-
lite and parent compound was evident regarding cytotoxic 
effects. Due to limited availability, 4-OH-AME could not 
be included in the testing.
AOH, AME and 4‑OH‑AOH influence the intracellular 
redox status
Hydroxylation in 4-position of AOH or AME generates a 
catecholic structure which might undergo redox cycling. 
Thus, the potential impact of 4-hydroxylation on the intra-
cellular ROS level was studied in KYSE510 cells using the 
dichlorofluorescein (DCF) assay. AOH, 4-OH-AOH and 
AME increased fluorescence intensity in a concentration-
dependent manner (Fig. 3). The highest concentration 
tested (50 µM) raised the signal to about 174 ± 5 % for 
AOH and 701 ± 229 % for 4-OH-AOH in comparison with 
the solvent control (1 % DMSO). In contrast, the mono-
methylether AME had only marginal impact on the ROS 
level (139 ± 8 % at 50 µM) of KYSE510 cells. Incuba-
tion with 4-OH-AME did not even affect the fluorescence 
signal. The ROS level generated by 50 µM 4-OH-AOH 
was significantly higher than that of the parent compound, 
whereas the fluorescence signal caused by 4-OH-AME 
did not exceed the signal of its parent substance. MEN 
(20 µM), a known redox cycler, was used as a positive con-
trol and increased fluorescence intensity to nearly twofold 
of the base level.
Table 1  Optimized ESI-MS and ESI-MS/MS parameters, retention times and LOD/LOQ values of the applied LC-ESI-MS/MS method
a Values are given in the order quantifier ion/qualifier ion
b Collision energy
c LOD was calculated based on a S/N ratio of 3:1
d LOQ was calculated based on a S/N ratio of 10:1
Analyte RT (min) Precursor ion (m/z) Ion species Product ionsa (m/z) CEa,b (V) LOD (ng/mL)c LOQ (ng/mL)d
AOH 3.6 257 [M–H]− 213/147 23/33 2.1 6.8
AME 9.2 271 [M–H]− 256/228 23/33 1.4 4.8
4-OH-AOH 1.9 273 [M–H]− 258/214 25/31 1.9 6.3
4-OH-AME 5.8 287 [M–H]− 272/188 23/32 2.6 8.8



























Fig. 2  Impact of AOH and 4-OH-AOH on the viability of KYSE510 
cells measured with the WST-1 assay in serum-containing medium 
after 24-h incubation. Triton X (0.1 %) was used as a positive con-
trol. The mitochondrial activity was calculated as incubated cells over 
control cells × 100 (%). The shown data are the mean ± SD of at 
least three independent experiments. Significances indicated display 
the significance level as compared to the respective control calculated 
by one-way ANOVA (*p < 0.05; **p < 0.01; ***p < 0.001)
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Activation of the ARE‑dependent Nrf2 pathway 
by AOH, 4‑OH‑AOH and AME
To gain more precise information on the mechanisms 
involved in the modulation of the redox status of KYSE510 
cells by the tested toxins, the impact on Nrf2, as a central 
regulator of cellular oxidative stress, was examined using 
an Nrf2 reporter gene assay. The Nrf2 pathway, leading 
to an activation of genes coding for phase II metabolizing 
enzymes, is induced by electrophiles or ROS. In transfected 
CHO-ARE-luciferase cells, the activated transcription fac-
tor Nrf2 specifically binds to the ARE coupled with the 
gene of Photinus pyralis luciferase in the nucleus and starts 
the expression of luciferase. After 20-h incubation, the bio-
luminescence signal was significantly raised concentration-
dependently by 4-OH-AOH to 1.3 ± 0.08-fold at 50 µM 
(Fig. 4). The highest luciferase activity was detected at 
25 µM AOH (1.4 ± 0.2-fold); nevertheless, no significant 
differences between the parent substance and the metabo-
lite was apparent. AME incubation resulted in an increased 
luciferase activity starting at a concentration of 10 µM 
(1.2 ± 0.1-fold), whereas no effects were detected after 
4-OH-AME incubation. AME and 4-OH-AME were not 
tested at 50 µM because of their limited solubility in 0.5 % 
DMSO, which was the limit for proper assay performance.
Inhibition of topoisomerase IIα activity by AOH, AME, 
4‑OH‑AOH and 4‑OH‑AME in a cell‑free system
Previous studies demonstrated that AOH interferes with 
human topoisomerases, an effect which is likely to at least 
contribute to the genotoxic properties of the compound. The 
impact of 4-hydroxylation on the activity of human topoi-
somerase II was investigated in the decatenation assay under 
cell-free conditions, exemplified for the topoisomerase IIα 
isoform using etoposide (ETO, 50 µM) as a positive control. 
Active topoisomerase II releases minicircles from the com-
plex high molecular kinetoplast DNA network (Fig. 6a, lane 
10, 6b, lane 11), thus enabling the released minicircles to 
migrate in the agarose gel (Fig. 6a, b, lane 1). Inhibition of 
topoisomerase II activity was already apparent at a concen-
tration of 10 µM 4-OH-AOH, and the enzyme activity was 
completely suppressed with 25 µM 4-OH-AOH (Fig. 6a, 
lane 8) as evident by the blunted release of free minicircles 
from the catenated kDNA by topoisomerase IIα. In con-
trast, AOH showed the first significant sign of suppression at 
50 µM (lane 5), even though the line of free DNA minicircles 

































Fig. 3  DCF assay with KYSE510 cells incubated for 1 h in serum-
free colorless medium with AOH, AME, 4-OH-AOH, 4-OH-AME 
and the positive control menadione (MEN). The increase in fluores-
cence intensity was measured with a fluorimeter using 485-nm excita-
tion and 535-nm emission filters. The level of formed reactive oxygen 
species was calculated as incubated cells over control cells (T/C). The 
data are presented as the mean ± SD of at least three independent 
experiments. Significances indicated display either (asterisk) the sig-
nificance level as compared to the respective negative control calcu-
lated by one-way ANOVA (*p < 0.05; **p < 0.01; ***p < 0.001) or 
indicate significant differences (a) between the highest tested concen-
tration (50 µM) of the four substances calculated by Student’s t test 
(a = p < 0.05)

























Fig. 4  Activation of Nrf2 induced ARE-dependent luciferase in 
CHO cells CHO-ARE luciferase cells were treated with AOH, AME, 
4-OH-AOH, 4-OH-AME (0.5 % DMSO) and the positive control 
100 nM CDDO for 20 h. ARE-driven luciferase expression was meas-
ured, normalized to the GFP fluorescence and expressed as the fold 
induction of the negative control. Values are mean ± SD of at least 
three independent experiments. Significant differences from the sol-
vent control 0.5 % DMSO were calculated using one-way ANOVA, 
followed by Fisher test (*p < 0.05; **p < 0.01; ***p < 0.001), and 
Student’s t test (a = p < 0.05) for the differences between the same 
concentrations of the four substances
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vanishes already at 10 µM (lane 3). A significant difference 
between AOH and 4-OH-AOH was present at a concentra-
tion of 25 µM. Thus, under cell-free conditions, the inhibi-
tory potential of the phase I metabolite 4-OH-AOH was 
more intense than for the parent compound. 10 µM AME 
inhibited the catalytic activity of topoisomerase IIα signifi-
cantly (Fig. 6b, lane 3). A complete blockage of the enzyme 
was apparent at 25 µM 4-OH-AME (Fig. 6b, lane 8), but 
there was no statistically significant difference between the 
metabolite and AME. Taken together, under cell-free condi-
tions, AOH appears as a less potent inhibitor of topoisomer-
ase IIα compared to AME and both 4-OH-metabolites.
Topoisomerase II poisoning by AOH, AME and the 
oxidative metabolites in KYSE510 cells
To verify topoisomerase inhibition on the cellular level, the 
ICE assay was used, determining the amount of cleavable 
complexes formed with DNA and topoisomerase IIα or IIβ 
in KYSE510 after 1-h incubation with 10 µM and 50 µM 
AOH, AME, 4-OH-AOH and 4-OH-AME. No topoisomer-
ase IIα–DNA complexes were detected for any of the test 
substances (data not shown). Topoisomerase IIβ–DNA 
complexes were significantly raised to 277 ± 107 % by 
AOH, 208 ± 61 % by 4-OH-AOH, 203 ± 38 % by AME 
and 143 ± 36 % by 4-OH-AME with the highest concen-
tration tested (Fig. 7). Yet, no statistically significant differ-
ences were found between the different test compounds.
DNA‑damaging potential of AOH, AME and their 
4‑hydroxy metabolites
Interference with topoisomerases as well as oxidative stress 
may cause DNA damage. The effects of AOH, AME and 
their 4-hydroxy metabolites on DNA integrity in KYSE510 
cells were determined in the comet assay after 1-h incuba-
tion. Formamidopyrimidine-DNA-glycosylase (FPG) was 
included in the comet assay protocol to detect FPG-sen-
sitive sites as an indication for oxidative DNA damage. A 
significant raise in tail intensities (5 ± 3.5 %, FPG-treated 
6.6 ± 1.4 %) mediated by 50 µM AOH was detected, 
whereas 4-OH-AOH (50 µM; 3.1 ± 0.4 %, FPG-treated 
3.7 ± 2.9 %) did not significantly affect DNA integrity. In 
contrast to AOH, neither significant increased DNA strand 
break levels nor additional oxidative DNA lesions after 
FPG treatment were observed for AME and 4-OH-AME.
Cellular uptake of AOH, AME and the hydroxylated 
metabolites
Considering the substantial discrepancy between the effects 
of the hydroxylated metabolites on topoisomerase II under 
cell-free conditions and the impact on DNA integrity in 
the comet assay, the question was addressed whether dif-
ferences in cellular uptake between the compounds might 
have to be considered. Cellular uptake of AOH, AME and 
their 4-hydroxylated metabolites was determined after 1-h 
incubation by analyzing the cell culture medium and the 
cell lysate by LC-MS/MS. A typical LC-MS/MS chroma-
togram is illustrated in Online Resource 2 (Supplement 
Fig. S1). In the cell lysate, the average amount of AOH 
was 304 ± 127 ng/mg protein and for AME 885 ± 269 ng/
mg protein (Fig. 8a). The concentration of 4-OH-AOH 
(2 ± 1 ng/mg protein) and 4-OH-AME (13 ± 1 ng/mg pro-
tein) in the cell lysate was substantially lower compared 
to the parent substances. The apparent recovery in the cell 
lysate matrix was 78 ± 1 % for AOH, 60 ± 7 % for AME 
as well as 59 ± 10 and 73 ± 10 % for 4-OH-AOH and 
4-OH-AME, respectively. No significant difference could 
be observed in the cell lysates after glucuronidase and sul-
fatase treatment. Neither newly formed hydroxylated prod-
ucts of AOH or AME nor a degeneration of 4-OH-AOH and 
4-OH-AME to AOH and AME, respectively, were found 
in the medium or the cell lysate after 1-h incubation time. 
Instead, incubations with 4-OH-AOH showed an additional 
peak in the chromatogram eluting after 3.6 min (see Online 
Resource 3; Supplement Fig. S2). A compound with an m/z 
of 287 and the same SRMs as 4-OH-AME was observed.
In the cell culture medium 5 ± 2.5 µM AOH (appar-
ent recovery 95 ± 28 %), 1.9 ± 0.5 µM AME (apparent 
recovery 104 ± 20 %), 1.3 ± 0.2 µM 4-OH-AOH (appar-
ent recovery 44 ± 12 %) and 0.4 µM 4-OH-AME (appar-
ent recovery 63 ± 18 %) were detected after 1-h incuba-
tion (Fig. 8b). Moreover, a significant difference in the 
analyzed culture medium of the 4-OH-AOH incubations 
was detected after sulfatase treatment when compared to 
the standard phosphate buffer samples. Also an increase 
in 4-OH-AOH in the medium after glucuronidase incuba-
tion was apparent but not yet significant. The other three 
substances revealed no differences between the standard 
incubation and the glucuronidase and sulfatase treatment 
(Fig. 8b).
Discussion
Alternaria toxins belong to the group of so-called emerg-
ing mycotoxins, being not regulated so far, but with more 
and more data demonstrating their frequency of occurrence 
in feed and food and their genotoxic properties. Previ-
ous studies already indicated under in vitro conditions the 
formation of oxidative metabolites of AOH and AME and 
the induction of oxidative stress (Burkhardt et al. 2011; 
Pahlke et al. 2015; Pfeiffer et al. 2007b). The present study 
investigated and compared the effects of AOH and AME 
to the phase I metabolites 4-OH-AOH and 4-OH-AME in 
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human esophageal cancer cells with respect to the induc-
tion of oxidative stress, the ability to target topoisomerase 
II as a central genotoxic mechanism of AOH and the conse-
quences for DNA integrity under consideration of cellular 
uptake and metabolism.
The fluorescence signal in the DCF assay, indicative 
for enhanced intracellular ROS levels in KYSE510 cells 
mediated by AOH (Fig. 3), was in accordance with previ-
ous data on the induction of oxidative stress by AOH in 
different cell lines (Fernández-Blanco et al. 2014; Pahlke 
et al. 2015; Solhaug et al. 2012; Tiessen et al. 2013a). In 
KYSE510 cells, AME was significantly less potent than 
AOH to enhance the intracellular ROS level, indicating 
that the methyl-moiety at C9-position might play a role. 
Of note, the cellular uptake of AME in KYSE510 cells was 
almost two times higher than for AOH (Fig. 8a), potentially 
due to the higher lipophilicity of AME. These data are con-
trary to the findings of Burkhardt et al. (2009) who reported 
a faster uptake for AOH than for AME in human colorec-
tal adenocarcinoma cells (Caco2) after 1-h incubation and 
a concentration of 20 µM. These results argue for the fact 
that the toxicokinetics of AOH and AME are cell-type spe-
cific. The phase I metabolite 4-OH-AME was found in a 
sixfold higher concentration in KYSE510 cells than 4-OH-
AOH; however, both in a much lower concentration when 
compared to the parent compounds. Of note, the amount 
of ROS was increased fourfold by 50 µM 4-OH-AOH as 
compared to AOH. This is in line with the assumption that 
catechols might lead to a higher generation of ROS due 
to redox cycling. Consequently, it would be reasonable to 
expect 4-OH-AME to produce higher amounts of ROS than 
AME. However, in the DCF assay, no increase in the fluo-
rescence signal was detected (Fig. 3).
The results of the DCF assay were supported by the data 
of the Nrf2 reporter gene assay (Fig. 4). Enhanced intracel-
lular levels of ROS are assumed to activate the redox-sensi-
tive transcription factor Nrf2 and subsequent reporter gene 
expression. Luciferase activity was indeed significantly 
increased by AOH, AME and 4-OH-AOH, whereas 4-OH-
AME turned out to be ineffective. The increase in luciferase 
activity in the CHO reporter gene system observed for 
AOH, its hydroxylated metabolite and AME did not com-
pletely reflect the DCF data obtained with KYSE510 cells, 
whereby the different cell types and assay protocols have to 
be taken into account. The observed Nrf2/ARE-activating 
potency of AOH in the CHO reporter gene assay is in line 
with earlier reports on the induction of the Nrf2-pathway in 
HT29 colon carcinoma cells resulting in enhanced levels of 
Nrf2/ARE-regulated detoxifying enzymes such as GST and 
γ-GCL (Tiessen et al. 2013a).
To further clarify the role of pro-oxidant properties of 
the mycotoxins and their hydroxylated metabolites with 
regard to genotoxicity, the DNA strand-breaking properties 
were analyzed in the comet assay (Fig. 5). However, the 
pro-oxidant properties of AOH, 4-OH-AOH and, to a lesser 
extent, AME, were not reflected by increased FPG-sensi-
tive sites in the DNA of KYSE510 cells. Previous studies 
indicated that oxidative stress does not play a predominant 
role in the induction of DNA damage by AOH and AME 
in HT29 cells (Tiessen et al. 2013a). However, enhanced 
levels of FPG-sensitive sites were reported in the murine 
macrophage cell line RAW 264.7 after 2-h exposure to 
AOH (Solhaug et al. 2012), indicating potential species dif-
ferences with respect to oxidative DNA damage. It is also 
likely that ROS generation could affect the cell membrane 
integrity by lipid peroxidation already stated by Fernández-
Blanco et al. (2014), who investigated in Caco2 colon car-
cinoma cells the effects of AOH on lipid peroxidation and 
antioxidant capacity of CAT and SOD. They found high 
levels of malondialdehyde, a biomarker for lipid peroxi-
dation (LPO), and increased SOD activity catalyzing the 
dismutation of superoxide anions to hydrogen peroxide. 
In conclusion, ROS production after exposure to AOH was 
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Fig. 5  Mediated DNA strand breaks measured with the comet assay 
in KYSE510 cells after 1-h incubation with AOH, AME and the 
metabolites 4-OH-AOH and 4-OH-AME in serum-free medium. 
1 % DMSO was used as a solvent control and UV light as a posi-
tive control. Further treatment with FPG allows detection of addi-
tional oxidative damage to DNA bases (dashed bars). Values are the 
means of at least three independent experiments ± SD, each per-
formed in duplicate. Significances indicated refer to either (asterisk) 
the significance level compared to the respective negative control 
calculated by one-way ANOVA, followed by Fisher test (*p < 0.05; 
**p < 0.01; ***p < 0.001), display significant differences (a) between 
FPG-treated and untreated samples calculated by Student’s t test 
(a = p < 0.05) or show significant differences between 50 µM AOH 
without FPG (b) 50 µM AOH with FPG treatment (c) and the three 
other substances calculated by one-way ANOVA, followed by Fisher 
test (b, c = p < 0.05)
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correlated with the enhancement of LPO in Caco2 cells 
and therefore might play a role in cell membrane damage 
instead of direct oxidative DNA damage. This could fur-
ther lead to an increased permeability for toxins resulting in 
cell death at a later stage (Matés 2000). After 24-h incuba-
tion of KYSE510 cells with 50 µM AOH or 4-OH-AOH, 
a significant decrease in about 40 and 50 %, respectively, 
in mitochondrial activity was detected in the WST-1 assay 
(Fig. 2). Although 4-OH-AOH induced a higher ROS pro-
duction than its parent compound, no significant difference 
was obvious between both regarding the impact on cell via-
bility of KYSE510 cells exposed to the highest concentra-
tion tested.
Previous studies demonstrated the topoisomerase poi-
soning properties of AOH, which is expected to at least 
contribute to its DNA-damaging properties. Under cell-
free conditions 4-OH-AOH had a greater impact on topoi-
somerase II activity than AOH (Fig. 6a), whereas AME 
and 4-OH-AME seemed to be working quite equal in the 
assay (Fig. 6b). However, in the ICE assay, detecting the 
impact of the test compounds on topoisomerase II within 
cells, it became apparent that the stronger topoisomer-
ase inhibitory effects of 4-OH-AOH and 4-OH-AME are 
limited to cell-free conditions. It is conceivable that the 
effects on cellular topoisomerase II could be attenuated 
by additional cellular responses, leading to detoxification 
of the substances or induction of DNA repair mechanisms 
as already shown in different cell lines (Fehr et al. 2010; 
Tiessen et al. 2013a; Solhaug et al. 2012). We previously 
demonstrated that AOH and AME act as topoisomerase II 
poisons in HT29 and A431 cells (Fehr et al. 2009), contrib-
uting to the genotoxic properties by affecting DNA integ-
rity (Tiessen et al. 2013b). In A431 cells, a preference of 
AOH for the topoisomerase IIα isoenzyme was indicated 
but only observed in a limited concentration range (Fehr 
et al. 2009). In KYSE510 cells, clearly enhanced levels of 
the covalent topoisomerase–DNA intermediate were only 
detected for the topoisomerase IIβ isoform (Fig. 7), which 
might hint at cell-type specific differences. Both isoforms 
have distinct patterns of expression and separate functions. 
Topoisomerase IIα is only expressed in proliferating cells 
and reaches a maximum during G2/M phase in the cell 
cycle. In contrast, the expression of IIβ is independent of 
the cell cycle and present in all human tissues (Austin and 
Marsh 1998; Ketron and Osheroff 2014). There was a ten-
dency of both 4-OH-metabolites to enhance the level of 
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Fig. 6  Catalytic activity of recombinant human topoisomerase IIα 
determined as the decatenation of kDNA. Topoisomerase IIα was 
incubated for 60 min at 37 °C with (a) AOH, 4-OH-AOH, (b) AME, 
4-OH-AME or the topoisomerase poison etoposide (PC, 50 µM). The 
reaction was stopped with a loading dye, and samples were directly 
separated by 1 % agarose gel electrophoresis. The stained gel was 
documented under UV light and fluorescence signals of decatenated 
kDNA treated with topoisomerase IIα, and the substances were cal-
culated as T/C (%) in comparison with the solvent control DMSO 
(NC). The data show the mean ± SD of at least three independent 
experiments. Significances compared to the respective control (aster-
isk) were calculated by one-way ANOVA, followed by Fisher test 
(*p < 0.05; **p < 0.01; ***p < 0.001). Additional significant dif-
ferences between the four substances with the same concentration 
were calculated by one-way ANOVA. Only the results of 25 µM 
AOH (a) or 50 µM AOH (b) differ from the other substances with 
the same concentration (a, b = p < 0.05). A representative agarose 
gel is depicted under the graph. Lane 1 showed the result of the sol-
vent control DMSO with kDNA exposed to topoisomerase II. Active 
topoisomerase II releases free DNA minicircles from catenated 
kDNA. Increasing concentrations of the parent compound (lane 2–5) 
and the metabolite (lane 6–9) demonstrate an inhibitory effect of the 
catalytic activity as well as the positive control ETO (a line 11 and b 
line 10). Lanes 10 (a) and 11 (b) represent catenated kDNA not incu-
bated with topoisomerase IIα
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covalent topoisomerase IIβ–DNA complexes, but to a lower 
extent compared to the respective parent compound and 
without reaching statistical significance. AME, 4-OH-AOH 
and 4-OH-AME appeared to be less effective to trap topoi-
somerase IIβ–DNA complexes compared to AOH, which is 
in line with the absence of DNA strand breaks in the comet 
assay for these three compounds (Fig. 5). Genotoxic effects 
of AOH and AME have already been described by Fehr 
et al. (2009) in HT29 and A431 cells in the same concen-
tration range where topoisomerase poisoning occurred. The 
question arises which mechanisms prevent the formation of 
DNA strand breaks in KYSE510 after AME, 4-OH-AOH 
and 4-OH-AME incubation, although inducing the stabili-
zation of topoisomerase IIβ–DNA complexes. Pfeiffer et al. 
(2007a) described DNA strand-breaking activities for AOH 
and AME in the alkaline unwinding assay after 1 h for both 
HT29 and HepG2, but after 24 h, DNA damage was only 
present in HepG2. The various outcomes of both cell lines 
can be explained by (1) the glucuronidation behavior and 
the associated detoxification of the toxins and (2) the onset 
of DNA repair pathways. After 24 h, no unconjugated sub-
stance was detected in the media of HT29 cells, whereas in 
HepG2 approximately 75 % were still present as AOH and 
AME (Pfeiffer et al. 2007a). In the esophagus, UGT1A7 is 
the most abundant UGT isoform; however, the expression 
level is relatively low compared to human liver, small intes-
tine and colon cells (Ohno and Nakajin 2009). Further-
more, AOH is a twice better substrate for UGT1A7 com-
pared to AME (Pfeiffer et al. 2009). Therefore, enhanced 
glucuronidation is not a suitable explanation for the lack of 
DNA damage for AME or 4-OH-AME incubation. Accord-
ingly, no sulfation or glucuronidation conjugates of AME 
and 4-OH-AME were detected after 1-h incubation (Fig. 8). 
Moreover, the amount of 4-OH-AME in the cell lysate was 
quite low compared to the concentration of AME, which 
might also explain the low impact on DNA damage.
Previously reported by Fehr et al. (2010), the human 
repair enzyme tyrosyl-DNA phosphodiesterase 1 (TDP1) 
is a vital factor for the modulation of AOH-mediated DNA 
damage by reducing covalent topoisomerase–DNA adducts. 
The study underlines the importance of TDP1 on the repair 
of topoisomerase-mediated DNA damage which might 
reduce the stabilized cleavable complexes by AME, 4-OH-
AOH and 4-OH-AME. However, another DNA repair 
process to connect DNA double strands after breakage is 
non-homologous end joining (NHEJ). The involvement 
of NHEJ after prolonged incubation in HCT116 cells was 
examined by Tiessen et al. (2013b). HCT116 cells treated 
with siRNA to suppress PCNA and Ku70, two proteins 
involved in the repair process of DNA double strand breaks 
via NHEJ, were used to determine AOH-mediated DNA 
lesions. The suppression of Ku70 and PCNA enhanced the 
DNA-damaging effect of AOH in the comet assay suggest-
ing that this process must be involved in DNA repair. In 
summary, the lower efficiency of AME, 4-OH-AME and 
4-OH-AOH to stabilize topoisomerase II–DNA complexes 
in association with potential DNA repair processes (NHEJ) 
and enzymes like TDP1 are feasible explanations for the 
low or rather non-DNA damage induced by these com-
pounds in KYSE510 cells.
Finally, the role of toxicokinetics and metabolism of 
these substances in KYSE510 cells was considered. As 
cytochrome P450 enzymes should occur commonly in 
esophageal cells (Lechevrel et al. 1999) and Pahlke et al. 
(2015) reported after 24-h incubation an induction of 
CYP1A1 transcripts and activity in KYSE510 cells by AOH 
and (less pronounced) by AME, hydroxylated products of 
AOH and AME should occur within the cells. However, 
hydroxylated compounds were neither present in the cell 









































Fig. 7  Detection of the covalent topoisomerase II–DNA complexes 
stabilized by the parent substances AOH, AME and their phase I 
metabolites in KYSE510 cells. Cells were treated with the test com-
pounds or the positive control etoposide (PC) for 1 h in serum-free 
medium. Cell lysate fractions were collected after centrifugation and 
blotted on a nitrocellulose membrane. Representative immunoblots of 
the DNA–positive fractions are depicted below the graph. The level 
of topoisomerase IIβ–DNA complexes was calculated as treated cells 
over control cells with respect to the DNA content × 100 (T/C, %). 
The data presented are the mean ± SD of at least three independent 
experiments. Significances indicated refer to the negative control 
DMSO (NC) and were calculated using one-way ANOVA followed 
by Fisher test (*p < 0.05; **p < 0.01; ***p < 0.001)
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lysate nor in the incubation medium after 1-h exposure, dem-
onstrating that at least the mediated DNA damage by AOH 
after 1 h can be ascribed to the parent compound. Addi-
tionally, glucuronidation and sulfation products of AOH 
and AME were not detected (Fig. 8) likely due to the short 
incubation time and low levels of UGTs in esophageal cells 
(Ohno and Nakajin 2009). After incubation of KYSE510 
cells with 4-OH-AOH or 4-OH-AME, the compounds were 
found in the cell lysate without evidence on the regeneration 
to AOH or AME in the cell culture medium and cell lysate. 
Fig. 8  Quantification of the 
parent compounds AOH and 
AME and their metabolites 
in the cell lysate (a) and the 
medium (b) after 1-h incuba-
tion in KYSE510 cells. Cells 
were treated with the respective 
test compounds (10 µM) for 
1 h at 37 °C, incubation media 
were collected, and cells were 
harvested and extracted with 
ethyl acetate. Cell lysates and 
incubation media were analyzed 
with HPLC-MS. Values shown 
are the mean ± SD of at least 
three independent experiments. 
Normality was tested accord-
ing to Shapiro–Wilk (p > 0.05). 
Significances indicated refer 
either to the differences between 
substance incubations calcu-
lated by one-way ANOVA, fol-
lowed by Fisher test (*p < 0.05; 
**p < 0.01; ***p < 0.001), 
differences between untreated 
and with enzyme (glucuroni-
dase, sulfatase) treated samples 
(repeated measurements 
ANOVA, followed by Fisher 
test; a = p < 0.05), differences 
to the parent substance AOH 
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The low concentration of 4-OH-AOH and 4-OH-AME 
in the cell lysate after incubation might be indicative for a 
poor cellular uptake resulting in the minor effects observed 
in the ICE- and comet assay. However, only low amounts of 
the initial concentration (10 µM) of 4-OH-AOH and 4-OH-
AME were present in the medium after 1 h, which could 
be the outcome of further metabolism like glucuronida-
tion, sulfation, GSH-conjugation or methylation. Following 
this consideration, incubations with 4-OH-AOH exhibited 
increased amounts of sulfation conjugates in the incubation 
medium (Fig. 8b) and an additional metabolism product 
(Supplement Fig. S2). Based on its m/z ratio of 287 and the 
retention behavior, we speculate that this peak might corre-
spond to a methylated product of 4-OH-AOH generated by 
catechol-O-methyl transferase (COMT). Indicative for the 
formation of methylated products is the fact that (1) Bur-
khardt et al. (2011) described the formation of 4-OH-AOH 
and 4-OH-AME methylation products at the catechol struc-
ture after incubation with rat liver cytosol containing COMT, 
and (2) COMT has been detected in all human tissues with 
the highest activity in the liver, followed by kidneys and gas-
trointestinal tract (Männistö and Kaakkola 1999). Therefore, 
it seems likely that methylation of 4-OH-AOH is a way of 
detoxification in KYSE510 cells, which might explain the 
minor effects in the other assays as compared to AOH. How-
ever, it could not be fully excluded that the detected com-
pound belongs to another hydroxyl isomer of AME such as 
2-OH-AME. Thus, further studies are needed to confirm the 
structure of the newly detected metabolite.
In summary, the potential phase I metabolites 4-OH-
AOH and 4-OH-AME were synthesized and systematically 
compared to the parent compounds with respect to oxida-
tive stress, DNA damage, topoisomerase inhibition, cellular 
uptake and metabolism. The results reveal that in KYSE510 
cells the catecholic structure of 4-OH-AOH and 4-OH-AME 
does not lead to enhanced levels of oxidative DNA damage 
although the redox cycling activity of 4-OH-AOH is at hand. 
Despite the huge induction of ROS by 4-OH-AOH, the tran-
scriptional activity of Nrf2 was not affected accordingly. The 
effects of the metabolites were minor compared to the respec-
tive parent substances AOH or AME in terms of topoisomer-
ase inhibition and DNA strand-breaking effects.
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